Abstract
BACKGROUND: alpha-Galactosylceramide (alpha-GalCer) can be presented by CD1d molecules of antigen-presenting cells, and is known to induce a potent NKT cell-dependent cytotoxic response against tumor cells. However, the main effector cells in alpha-GalCer-induced antitumor immunity are still controversial. METHODS: In order to elucidate the cell phenotype that plays the most important role in alpha-GalCer-induced antitumor immunity, we purified and analyzed tumor-infiltrating leukocytes (TILs) from liver metastatic nodules of a colon cancer cell line (Colon26), comparing alpha-GalCer- and control vehicle-treated mice. Flow cytometry was performed to analyze cell phenotype in TILs and IFN-gamma ELISA was performed to detect antigen-specific immune response. RESULTS: Flow cytometry analysis showed a significantly higher infiltration of NK cells (DX5+, T cell receptor alphabeta (TCR)-) into tumors in alpha-GalCer-treated mice compared to vehicle-treated mice. The DX5+TCR+ cell population was not significantly different between these two groups, indicating that these cells were not the main effector cells. Interestingly, the CD8+ T cell population was increased in TILs of alpha-GalCer-treated mice, and the activation level of these...Continue Reading
References
Oct 1, 1993·Pathology·N A Zeid, H K Muller
Jan 1, 1997·Annual Review of Medicine·L B Saltz, D P Kelsen
May 1, 1997·Nature Medicine·J GongD Kufe
Jan 1, 1997·Annual Review of Immunology·A BendelacJ H Roark
Dec 31, 1997·Science·T KawanoM Taniguchi
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·T KawanoM Taniguchi
Oct 23, 1998·The Journal of Experimental Medicine·L BrossayM Kronenberg
Oct 23, 1998·The Journal of Experimental Medicine·F M SpadaS A Porcelli
Feb 24, 2000·The Journal of Experimental Medicine·M J SmythD I Godfrey
Apr 13, 2000·European Journal of Immunology·G Eberl, H R MacDonald
Jun 6, 2000·International Immunology·K TakedaK Okumura
Jul 6, 2000·International Immunology·T NishimuraT Koda
Feb 8, 2003·Lancet·Andrea Bonetti
Citations
Jun 8, 2011·International Journal of Colorectal Disease·Matthias HornungEdward K Geissler
Mar 20, 2012·Lipids·Masashi InafukuHisami Watanabe
May 3, 2011·BMC Immunology·Jens M WernerMatthias Hornung
May 15, 2008·Expert Opinion on Biological Therapy·Elena AmbrosinoMasaki Terabe
May 14, 2011·Expert Opinion on Therapeutic Targets·Caroline C Duwaerts, Stephen H Gregory
Sep 13, 2005·Journal of Theoretical Biology·L G de PillisA E Radunskaya
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel G PellicciDale I Godfrey